• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新辅助化疗后乳腺癌前哨淋巴结活检的可靠性。

Reliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients.

机构信息

Department of Surgery, Seoul National University Hospital, Seoul, Korea.

Department of Pathology, Seoul National University Hospital, Seoul, Korea.

出版信息

J Breast Cancer. 2013 Dec;16(4):378-85. doi: 10.4048/jbc.2013.16.4.378. Epub 2013 Dec 31.

DOI:10.4048/jbc.2013.16.4.378
PMID:24454459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3893339/
Abstract

PURPOSE

Sentinel lymph node biopsy (SLNB) is an accurate and effective means of axillary nodal staging in early breast cancer. However its indication after neoadjuvant chemotherapy (NAC) is under constant debate. The present study evaluates the reliability of SLNB in assessing axillary nodal status after NAC.

METHODS

Data from 281 patients who had received NAC and subsequent SLNB were reviewed. The identification and false negative rates of SLNB were determined and the clinicopathologic factors associated with false negative results were investigated using univariate analysis.

RESULTS

The identification rate of SLNB after NAC was 93.6% and the false negative rate was 10.4%. Hormone receptor status, especially progesterone receptor positivity, was significantly associated with false negative results. The accuracy of intraoperative frozen section examination of sentinel lymph nodes was 91.2%.

CONCLUSION

The identification rate of SLNB and the accuracy of intraoperative frozen section examination after NAC are comparable to the results without NAC in patients with early breast cancer. However considering the high false negative rates, general application of SLNB after NAC should be avoided. Patients with progesterone-positive tumors and non-triple-negative breast cancers may be a select group of patients in whom SLNB can be employed safely after NAC, but further studies are necessary.

摘要

目的

前哨淋巴结活检(SLNB)是早期乳腺癌腋窝淋巴结分期的一种准确、有效的方法。然而,新辅助化疗(NAC)后其适应证仍存在争议。本研究旨在评估 SLNB 在评估 NAC 后腋窝淋巴结状态方面的可靠性。

方法

回顾性分析了 281 例接受 NAC 及随后 SLNB 的患者资料。确定 SLNB 的检出率和假阴性率,并采用单因素分析方法探讨与假阴性结果相关的临床病理因素。

结果

NAC 后 SLNB 的检出率为 93.6%,假阴性率为 10.4%。激素受体状态,特别是孕激素受体阳性,与假阴性结果显著相关。术中冰冻切片检查哨兵淋巴结的准确率为 91.2%。

结论

NAC 后 SLNB 的检出率和术中冰冻切片检查的准确率与未接受 NAC 的早期乳腺癌患者相似。然而,考虑到假阴性率较高,应避免常规应用 NAC 后的 SLNB。孕激素阳性肿瘤和非三阴性乳腺癌患者可能是一组可以安全应用 NAC 后 SLNB 的患者,但仍需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75d8/3893339/5b1b20b5373c/jbc-16-378-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75d8/3893339/5b1b20b5373c/jbc-16-378-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75d8/3893339/5b1b20b5373c/jbc-16-378-g001.jpg

相似文献

1
Reliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients.新辅助化疗后乳腺癌前哨淋巴结活检的可靠性。
J Breast Cancer. 2013 Dec;16(4):378-85. doi: 10.4048/jbc.2013.16.4.378. Epub 2013 Dec 31.
2
Update on sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patient.新辅助化疗后乳腺癌前哨淋巴结活检的最新进展。
Ann Ital Chir. 2020;91:465-468.
3
Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer.新辅助化疗后细胞学证实淋巴结阳性乳腺癌的前哨淋巴结活检。
Clin Breast Cancer. 2013 Dec;13(6):471-7. doi: 10.1016/j.clbc.2013.08.014.
4
Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.乳腺癌新辅助化疗后的腋窝分期:一项将前哨淋巴结活检与治疗前阳性腋窝淋巴结放射性粒子定位相结合的初步研究。
Ann Surg Oncol. 2016 May;23(5):1549-53. doi: 10.1245/s10434-015-5052-8. Epub 2016 Jan 4.
5
Sentinel lymph node biopsy does not apply to all axillary lymph node-positive breast cancer patients after neoadjuvant chemotherapy.前哨淋巴结活检不适用于所有新辅助化疗后腋窝淋巴结阳性的乳腺癌患者。
Thorac Cancer. 2014 Nov;5(6):550-5. doi: 10.1111/1759-7714.12131. Epub 2014 Oct 23.
6
Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy.一步法核酸扩增(OSNA)术中前哨淋巴结活检可避免新辅助化疗治疗乳腺癌女性行腋窝淋巴结清扫术。
Eur J Surg Oncol. 2013 Aug;39(8):873-9. doi: 10.1016/j.ejso.2013.05.002. Epub 2013 May 25.
7
A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer.新辅助化疗后采用改良靛胭脂蓝染料法对乳腺癌前哨淋巴结活检的前瞻性可行性研究。
Eur J Surg Oncol. 2015 Apr;41(4):566-70. doi: 10.1016/j.ejso.2014.10.066. Epub 2015 Jan 22.
8
Refining the Performance of Sentinel Lymph Node Biopsy Post-neoadjuvant Chemotherapy in Patients with Pathologically Proven Pre-treatment Node-positive Breast Cancer: An Update for Clinical Practice.优化新辅助化疗后经病理证实治疗前淋巴结阳性乳腺癌患者前哨淋巴结活检的性能:临床实践更新
Anticancer Res. 2016 Apr;36(4):1461-71.
9
The Feasibility and Reliability of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Breast Cancer Patients With Negative Axillary Lymph Nodes-A Meta-analysis.新辅助化疗后腋窝淋巴结阴性乳腺癌患者前哨淋巴结活检的可行性和可靠性——一项荟萃分析
Breast Cancer (Auckl). 2024 May 30;18:11782234241255856. doi: 10.1177/11782234241255856. eCollection 2024.
10
Correlation between clinical nodal status and sentinel lymph node biopsy false negative rate after neoadjuvant chemotherapy.新辅助化疗后临床淋巴结状态与前哨淋巴结活检假阴性率的相关性。
World J Surg. 2012 Dec;36(12):2847-52. doi: 10.1007/s00268-012-1704-z.

引用本文的文献

1
Estimation of Hand Function Impairment in Breast Cancer Survivors with Lymphedema.乳腺癌淋巴水肿幸存者手部功能损伤的评估
South Asian J Cancer. 2024 Feb 16;14(1):23-29. doi: 10.1055/s-0044-1779301. eCollection 2025 Jan.
2
The Feasibility and Reliability of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Breast Cancer Patients With Negative Axillary Lymph Nodes-A Meta-analysis.新辅助化疗后腋窝淋巴结阴性乳腺癌患者前哨淋巴结活检的可行性和可靠性——一项荟萃分析
Breast Cancer (Auckl). 2024 May 30;18:11782234241255856. doi: 10.1177/11782234241255856. eCollection 2024.
3
Lymphoscintigraphy in patients with breast cancer-related lymphedema after sentinel lymph node dissection and axillary radiation therapy.

本文引用的文献

1
Correlation between clinical nodal status and sentinel lymph node biopsy false negative rate after neoadjuvant chemotherapy.新辅助化疗后临床淋巴结状态与前哨淋巴结活检假阴性率的相关性。
World J Surg. 2012 Dec;36(12):2847-52. doi: 10.1007/s00268-012-1704-z.
2
The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer.新辅助化疗后前哨淋巴结活检在淋巴结阳性乳腺癌患者中的作用。
Ann Surg Oncol. 2012 Oct;19(10):3177-84. doi: 10.1245/s10434-012-2484-2. Epub 2012 Jul 7.
3
Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy.
前哨淋巴结活检和腋窝放射治疗后乳腺癌相关淋巴水肿患者的淋巴闪烁显像。
Medicine (Baltimore). 2022 Dec 9;101(49):e31985. doi: 10.1097/MD.0000000000031985.
4
Outcomes of Sentinel Node Biopsy for Women with Breast Cancer After Neoadjuvant Therapy: Systematic Review and Meta-Analysis of Real-World Data.新辅助治疗后乳腺癌女性前哨淋巴结活检的结果:真实世界数据的系统评价和荟萃分析。
Ann Surg Oncol. 2022 May;29(5):3038-3049. doi: 10.1245/s10434-021-11297-z. Epub 2022 Jan 11.
5
Allicin induces cell cycle arrest and apoptosis of breast cancer cells in vitro via modulating the p53 pathway.蒜素通过调节p53通路在体外诱导乳腺癌细胞的细胞周期停滞和凋亡。
Mol Biol Rep. 2021 Nov;48(11):7261-7272. doi: 10.1007/s11033-021-06722-1. Epub 2021 Oct 9.
6
Sentinel lymph node mapping in breast cancer patients following neoadjuvant chemotherapy: systematic review and meta-analysis about head to head comparison of cN0 and cN + patients.新辅助化疗后乳腺癌患者前哨淋巴结活检:cN0 和 cN+患者头对头比较的系统评价和荟萃分析。
Breast Cancer. 2022 Jan;29(1):50-64. doi: 10.1007/s12282-021-01280-7. Epub 2021 Aug 2.
7
Targeted axillary biopsy and sentinel lymph node biopsy for axillary restaging after neoadjuvant chemotherapy.新辅助化疗后用于腋窝再分期的靶向腋窝活检和前哨淋巴结活检。
Ann Surg Treat Res. 2021 Jun;100(6):305-312. doi: 10.4174/astr.2021.100.6.305. Epub 2021 Jun 1.
8
Prognosis according to clinical and pathologic lymph node status in breast cancer patients who underwent sentinel lymph node biopsy alone after neoadjuvant therapy.新辅助治疗后单独行前哨淋巴结活检的乳腺癌患者的临床和病理淋巴结状态的预后。
PLoS One. 2021 May 18;16(5):e0251597. doi: 10.1371/journal.pone.0251597. eCollection 2021.
9
Minimal Invasive and Individualizing Management of the Axillary Nodes.微创与个体化腋窝淋巴结管理。
Adv Exp Med Biol. 2021;1187:591-599. doi: 10.1007/978-981-32-9620-6_31.
10
Development and validation of a nomogram for prediction of lymph node metastasis in early-stage breast cancer.早期乳腺癌淋巴结转移预测列线图的开发与验证
Gland Surg. 2021 Mar;10(3):901-913. doi: 10.21037/gs-20-782.
乳腺癌亚型与新辅助化疗病理完全缓解相关性的荟萃分析。
Eur J Cancer. 2012 Dec;48(18):3342-54. doi: 10.1016/j.ejca.2012.05.023. Epub 2012 Jul 3.
4
Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation.新辅助化疗后前哨淋巴结活检可预测就诊时临床腋窝淋巴结阳性的乳腺癌患者的腋窝病理淋巴结状态。
Int J Clin Oncol. 2013 Jun;18(3):547-53. doi: 10.1007/s10147-012-0418-4. Epub 2012 May 16.
5
Feasibility of sentinel lymph node biopsy in breast cancer patients with initial axillary lymph node metastasis after primary systemic therapy.原发系统性治疗后初始腋窝淋巴结转移的乳腺癌患者前哨淋巴结活检的可行性。
J Breast Cancer. 2011 Jun;14(2):147-52. doi: 10.4048/jbc.2011.14.2.147. Epub 2011 Jun 18.
6
Accuracy of sentinel lymph node biopsy after neo-adjuvant chemotherapy in patients with locally advanced breast cancer and clinically positive axillary nodes.新辅助化疗后局部晚期乳腺癌伴临床阳性腋窝淋巴结患者前哨淋巴结活检的准确性。
Eur J Surg Oncol. 2011 Aug;37(8):688-94. doi: 10.1016/j.ejso.2011.05.012. Epub 2011 Jun 22.
7
The feasibility and accuracy of sentinel lymph node biopsy in clinically node-negative patients after neoadjuvant chemotherapy for breast cancer--a systematic review and meta-analysis.新辅助化疗后临床淋巴结阴性乳腺癌患者前哨淋巴结活检的可行性和准确性——系统评价和荟萃分析。
J Surg Oncol. 2011 Jul 1;104(1):97-103. doi: 10.1002/jso.21911. Epub 2011 Mar 24.
8
Sentinel lymph node biopsy in breast cancer patients treated with neoadjuvant chemotherapy.新辅助化疗的乳腺癌患者前哨淋巴结活检。
Cancer. 2011 Oct 15;117(20):4606-16. doi: 10.1002/cncr.26102. Epub 2011 Mar 22.
9
Sentinel lymph node biopsy is precise after primary systemic therapy in stage II-III breast cancer patients.前哨淋巴结活检在 II-III 期乳腺癌患者的初始全身治疗后具有较高的准确性。
Ann Surg Oncol. 2010 Oct;17 Suppl 3:286-90. doi: 10.1245/s10434-010-1246-2. Epub 2010 Sep 19.
10
Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatment.治疗前已确诊淋巴结阳性乳腺癌患者,术前化疗后前哨淋巴结假阴性相关组织学变化。
Cancer. 2010 Jun 15;116(12):2878-83. doi: 10.1002/cncr.25066.